Lakefront Biotherapeutics (LKFT) Sales of Property, Plant and Equipment (2015 - 2026)
Powered by 
Analysis
Lakefront Biotherapeutics (LKFT) Sales of Property, Plant and Equipment (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Sales of Property, Plant and Equipment (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | 5.85 Mn |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | - |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | - |
| 10 | Lakefront Biotherapeutics | 1.88 Bn | 1.88 Bn | 3.51 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 1.54 Mn |
| Dec 31, 2025 | 449,320.80 |
| Sep 30, 2025 | 26.68 Mn |
| Dec 31, 2023 | 131,264.67 |
| Dec 31, 2022 | 20,404.95 |
| Dec 31, 2019 | -1,106.89 |
| Sep 30, 2019 | -1,112.73 |
| Jun 30, 2019 | 1,123.64 |
| Mar 31, 2019 | 1,136.63 |
| Dec 31, 2018 | -1,141.40 |
| Mar 31, 2018 | 1,228.53 |
| Dec 31, 2017 | 1,177.43 |
| Jun 30, 2017 | 13.19 Mn |
| Mar 31, 2017 | 1,065.41 |
| Dec 31, 2016 | -15,116.14 |
| Mar 31, 2016 | 17,648.20 |
| Dec 31, 2015 | -67,959.27 |